• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经源性逼尿肌过度活动患者的鞘氨醇激酶1在尿路上皮的表达增加。

Sphingosine Kinase 1 urothelial expression is increased in patients with neurogenic detrusor overactivity.

作者信息

Ballouhey Quentin, Panicker Jalesh N, Mazerolles Catherine, Roumiguie Mathieu, Zaidi Falek, Rischmann Pascal, Malavaud Bernard, Game Xavier

机构信息

Departement d'Urologie, CHU Rangueil, Toulouse, France.

Department of Uro-Neurology, UCL Institute of Neurology, The National Hospital for Neurology and Neurosurgery, Queen Square, London, WC1N 3BG, United Kingdom.

出版信息

Int Braz J Urol. 2015 Nov-Dec;41(6):1141-7. doi: 10.1590/S1677-5538.IBJU.2014.0676.

DOI:10.1590/S1677-5538.IBJU.2014.0676
PMID:26742972
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4756940/
Abstract

UNLABELLED

To evaluate the expression of sphingosine kinase 1 (SPK1) in the bladder wall in patients with neurogenic lower urinary tract dysfunction and its association with clinical, urodynamic and pathological features.

MATERIALS AND METHODS

The expression of SPK1 was studied in bladder wall specimens obtained from cystectomy using immunohistochemistry in ten patients with spinal cord injury (n=8) or multiple sclerosis (n=2) with urodynamically proven neuropathic bladder dysfunction, and in controls (n=5). Inflammation and fibrosis were analysed with histological criteria and SPK1 expression was determined by individual immunohistochemical staining.

RESULTS

Significant increased SPK1 urothelial immunoreactivity was shown in patients compared to control group (p=0.03). By contrast, SPK1 immunoreactivity in patients was significantly decreased in the sub-urothelium, muscles and nerves, p=0.02; 0.01 and 0.003, respectively. Patients with neurogenic detrusor overactivity (NDO) had higher SPK1 urothelium expression than those without any DO (p=0.04).

CONCLUSIONS

SPK1 is expressed in the human bladder wall, specifically the urothelium, in bladder specimens from patients with NDO. The role of SPK1 in the pathophysiology of NDO needs further elucidation.

摘要

未标注

评估神经源性下尿路功能障碍患者膀胱壁中鞘氨醇激酶1(SPK1)的表达及其与临床、尿动力学和病理特征的关联。

材料与方法

采用免疫组织化学方法,对10例经尿动力学证实为神经源性膀胱功能障碍的脊髓损伤患者(n = 8)或多发性硬化患者(n = 2)以及对照组(n = 5)膀胱切除术获取的膀胱壁标本中SPK1的表达进行研究。采用组织学标准分析炎症和纤维化情况,并通过个体免疫组织化学染色测定SPK1表达。

结果

与对照组相比,患者的SPK1尿路上皮免疫反应性显著增加(p = 0.03)。相比之下,患者尿路上皮下层、肌肉和神经中的SPK1免疫反应性显著降低,p值分别为0.02、0.01和0.003。神经源性逼尿肌过度活动(NDO)患者的SPK1尿路上皮表达高于无任何逼尿肌过度活动的患者(p = 0.04)。

结论

在NDO患者的膀胱标本中,SPK1在人膀胱壁中表达,特别是在尿路上皮中。SPK1在NDO病理生理学中的作用需要进一步阐明。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbcc/4756940/9ce4a7a4cfde/1677-5538-ibju-41-6-1141-gf03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbcc/4756940/6bc3c93ac06a/1677-5538-ibju-41-6-1141-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbcc/4756940/506e71d96acf/1677-5538-ibju-41-6-1141-gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbcc/4756940/9ce4a7a4cfde/1677-5538-ibju-41-6-1141-gf03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbcc/4756940/6bc3c93ac06a/1677-5538-ibju-41-6-1141-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbcc/4756940/506e71d96acf/1677-5538-ibju-41-6-1141-gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbcc/4756940/9ce4a7a4cfde/1677-5538-ibju-41-6-1141-gf03.jpg

相似文献

1
Sphingosine Kinase 1 urothelial expression is increased in patients with neurogenic detrusor overactivity.神经源性逼尿肌过度活动患者的鞘氨醇激酶1在尿路上皮的表达增加。
Int Braz J Urol. 2015 Nov-Dec;41(6):1141-7. doi: 10.1590/S1677-5538.IBJU.2014.0676.
2
Single onabotulinumtoxinA 200U dose improved clinical symptoms but not urothelial dysfunction in neurogenic detrusor overactivity due to spinal cord injury.单次注射 200U 肉毒毒素能改善临床症状,但不能改善因脊髓损伤导致的神经源性逼尿肌过度活动引起的尿路上皮功能障碍。
J Formos Med Assoc. 2019 Jan;118(1 Pt 1):125-133. doi: 10.1016/j.jfma.2018.02.002. Epub 2018 Mar 2.
3
Multiple sclerosis produces significant changes in urinary bladder innervation which are partially reflected in the lower urinary tract functional status-sensory nerve fibers role in detrusor overactivity.多发性硬化会导致膀胱神经支配发生显著变化,这在一定程度上反映在下尿路功能状态中——感觉神经纤维在逼尿肌过度活动中的作用。
Mult Scler. 2009 Jul;15(7):860-8. doi: 10.1177/1352458509106210.
4
Supratrigonal cystectomy with Hautmann pouch as treatment for neurogenic bladder in spinal cord injury patients: long-term functional results.经耻骨上囊-Hautmann 袋膀胱切除术治疗脊髓损伤患者神经原性膀胱:长期功能结果。
Neurourol Urodyn. 2012 Jun;31(5):672-6. doi: 10.1002/nau.21239. Epub 2012 Apr 24.
5
OnabotulinumtoxinA improves urodynamic outcomes in patients with neurogenic detrusor overactivity.肉毒毒素 A 能改善神经原性逼尿肌过度活动患者的尿动力学结果。
Neurourol Urodyn. 2013 Nov;32(8):1109-15. doi: 10.1002/nau.22376. Epub 2013 Feb 6.
6
Histological changes in the urothelium and suburothelium of human overactive bladder following intradetrusor injections of botulinum neurotoxin type A for the treatment of neurogenic or idiopathic detrusor overactivity.膀胱内注射A型肉毒杆菌神经毒素治疗神经源性或特发性逼尿肌过度活动后,人膀胱过度活动症患者膀胱上皮及上皮下组织的组织学变化
Eur Urol. 2008 Jun;53(6):1245-53. doi: 10.1016/j.eururo.2008.02.037. Epub 2008 Mar 7.
7
Nerve sprouting and neurogenic inflammation characterize the neurogenic detrusor overactive bladder of patients no longer responsive to drug therapies.神经末梢生长和神经原性炎症是神经源性逼尿肌过度活动症的特征,此类患者对药物治疗不再有反应。
J Cell Mol Med. 2019 Jun;23(6):4076-4087. doi: 10.1111/jcmm.14294. Epub 2019 Apr 3.
8
Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial.经尿道前列腺切除术治疗良性前列腺增生术后出血的危险因素分析
Eur Urol. 2011 Oct;60(4):742-50. doi: 10.1016/j.eururo.2011.07.002. Epub 2011 Jul 13.
9
γEpithelial Na(+) Channel (γENaC) and the Acid-Sensing Ion Channel 1 (ASIC1) expression in the urothelium of patients with neurogenic detrusor overactivity.
BJU Int. 2015 Nov;116(5):797-804. doi: 10.1111/bju.12896. Epub 2015 Jun 2.
10
Endoscopic treatment of vesicoureteral reflux with non-simultaneous involuntary detrusor contraction in chronic spinal cord injury patients with neurogenic detrusor overactivity.慢性脊髓损伤合并神经源性逼尿肌过度活动患者非同步性逼尿肌不自主收缩时的膀胱输尿管反流内镜治疗
Urol Int. 2014;93(4):399-402. doi: 10.1159/000357440. Epub 2014 Mar 12.

引用本文的文献

1
The Urothelium: Life in a Liquid Environment.尿路上皮:液体环境中的生命。
Physiol Rev. 2020 Oct 1;100(4):1621-1705. doi: 10.1152/physrev.00041.2019. Epub 2020 Mar 19.
2
Modulation of lower urinary tract smooth muscle contraction and relaxation by the urothelium.尿路上皮对下尿路平滑肌收缩和舒张的调节作用。
Naunyn Schmiedebergs Arch Pharmacol. 2018 Jul;391(7):675-694. doi: 10.1007/s00210-018-1510-8. Epub 2018 May 28.
3
Urothelial proliferation and regeneration after spinal cord injury.脊髓损伤后尿路上皮的增殖与再生

本文引用的文献

1
Urothelial signaling.尿路上皮信号转导
Physiol Rev. 2013 Apr;93(2):653-80. doi: 10.1152/physrev.00030.2012.
2
Non-adrenergic, non-cholinergic, non-purinergic contractions of the urothelium/lamina propria of the pig bladder.猪膀胱尿路上皮/固有层的非肾上腺素能、非胆碱能、非嘌呤能收缩
Auton Autacoid Pharmacol. 2012 Oct;32(3 Pt 4):53-9. doi: 10.1111/aap.12000.
3
Expression profiling of G-protein-coupled receptors in human urothelium and related cell lines.人尿路上皮及其相关细胞系中 G 蛋白偶联受体的表达谱分析。
Am J Physiol Renal Physiol. 2017 Jul 1;313(1):F85-F102. doi: 10.1152/ajprenal.00592.2016. Epub 2017 Mar 22.
BJU Int. 2012 Sep;110(6 Pt B):E293-300. doi: 10.1111/j.1464-410X.2012.011145.x. Epub 2012 May 3.
4
Treatments for relapsing-remitting multiple sclerosis: summarising current information by network meta-analysis.复发缓解型多发性硬化症的治疗:通过网络荟萃分析总结当前信息。
Eur J Clin Pharmacol. 2012 Apr;68(4):441-8. doi: 10.1007/s00228-011-1141-1. Epub 2011 Nov 5.
5
Pathophysiology of the urothelium and detrusor.尿路上皮和逼尿肌的病理生理学
Can Urol Assoc J. 2011 Oct;5(5 Suppl 2):S128-30. doi: 10.5489/cuaj.11181.
6
Multiple sclerosis treatment: First oral drug, new antibody therapies.多发性硬化症治疗:首款口服药物、新型抗体疗法。
JAAPA. 2011 Aug;24(8):54, 56. doi: 10.1097/01720610-201108000-00012.
7
Basic bladder neurophysiology.基本膀胱神经生理学。
Urol Clin North Am. 2010 Nov;37(4):487-94. doi: 10.1016/j.ucl.2010.06.006.
8
Vessel-specific role of sphingosine kinase 1 in the vasoconstriction of isolated basilar arteries.鞘氨醇激酶 1 在分离基底动脉血管收缩中的血管特异性作用。
Pharmacol Res. 2010 Dec;62(6):465-74. doi: 10.1016/j.phrs.2010.09.002. Epub 2010 Sep 17.
9
The sphingosine-1-phosphate pathway is upregulated in response to partial urethral obstruction in male rats and activates RhoA/Rho-kinase signalling.鞘氨醇-1-磷酸途径在雄性大鼠部分尿道梗阻时上调,并激活 RhoA/Rho 激酶信号通路。
BJU Int. 2010 Aug;106(4):562-71. doi: 10.1111/j.1464-410X.2009.09156.x. Epub 2010 Jan 29.
10
Regional heterogeneity in expression of the sphingosine-1-phosphate pathway in the female rat lower urinary tract.雌性大鼠下尿路中鞘氨醇-1-磷酸途径表达的区域异质性。
Am J Obstet Gynecol. 2009 May;200(5):576.e1-7. doi: 10.1016/j.ajog.2008.12.007. Epub 2009 Feb 28.